Compare IESC & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IESC | NEOG |
|---|---|---|
| Founded | 1997 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 2.7B |
| IPO Year | 1997 | 1995 |
| Metric | IESC | NEOG |
|---|---|---|
| Price | $226.47 | $12.48 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 295.2K | ★ 3.9M |
| Earning Date | 11-20-2026 | 10-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 51.87 | ★ 99.20 |
| EPS | ★ 17.52 | N/A |
| Revenue | ★ $3,371,468,000.00 | $870,400,000.00 |
| Revenue This Year | $25.64 | $2.03 |
| Revenue Next Year | $48.14 | N/A |
| P/E Ratio | $12.38 | ★ N/A |
| Revenue Growth | ★ 16.89 | N/A |
| 52 Week Low | $210.50 | $5.37 |
| 52 Week High | $816.51 | $14.26 |
| Indicator | IESC | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 26.69 | 54.18 |
| Support Level | N/A | $11.25 |
| Resistance Level | $349.66 | $12.85 |
| Average True Range (ATR) | 13.99 | 0.48 |
| MACD | -1.10 | 0.03 |
| Stochastic Oscillator | 17.32 | 88.26 |
IES Holdings Inc owns and manages subsidiaries that design and installs integrated electrical and technology systems and provide infrastructure products and services. It has four business segments; Communications, Residential, Infrastructure Solutions, and Commercial & Industrial. The majority of the revenue for the company is generated from its Residential segment in which the company provides electrical installation services for single-family housing and multi-family apartment complexes, as well as heating, ventilation, and air conditioning (HVAC) and plumbing installation services. This segment also provides services for installing residential solar power, both for new construction and existing residences.
Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.